Sodium ferric gluconate complex

Clinical data
Trade names	Ferrlecit
AHFS/Drugs.com	FDA Professional Drug Information
Pregnancy category	US: B (No risk in non-human studies)
Legal status	US: ℞-only
Routes of administration	Intravenous
Identifiers
ATC code	B03AC
Chemical data

Sodium ferric gluconate complex (brand name Ferrlecit by Sanofi), is an intravenously administered iron product indicated in the treatment of iron deficiency anemia. It is frequently used in patients undergoing hemodialysis, those undergoing erythropoietin therapy, and/or patients who have chronic kidney disease.

References

Other hematological agents

Antianemic
preparations
(B03)

Erythropoietins	Darbepoetin alfa Methoxy polyethylene glycol-epoetin beta Peginesatide

Iron supplements	Ferrous ascorbate Ferrous aspartate Ferrous carbonate Ferrous chloride Ferrous fumarate Ferrous gluconate Ferrous glycine sulfate Ferrous iodine Ferrous succinate Ferrous sulfate Ferrous tartrate Iron sucrose Sodium ferric gluconate complex

Blood
substitutes and
perfusion solutions
(B05)

Dextran
Gelatin agents
Hemoglobin crosfumaril
Hemoglobin raffimer
Hydroxyethyl starch
Icodextrin
Mannitol
Serum albumin
Sorbitol

Enzymes
(B06AA)

Drugs used in
hereditary
angioedema
(B06AC)

Index of cells from bone marrow

Description	Immune system Cells Physiology coagulation proteins granule contents colony-stimulating heme and porphyrin metabolism intermediates

Disease	Red blood cell Monocyte and granulocyte Neoplasms and cancer Histiocytosis Symptoms and signs eponymous Blood tests findings

Treatment	Transfusion Drugs thrombosis bleeding other